Reproducibility of human immunodeficiency virus type 1 (HIV-1) protease and reverse transcriptase sequencing of plasma samples from heavily treated HIV-1-infected individuals

被引:25
|
作者
Shafer, RW [1 ]
Warford, A [1 ]
Winters, MA [1 ]
Gonzales, MJ [1 ]
机构
[1] Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA
关键词
HIV-1; protease; reverse transcriptase;
D O I
10.1016/S0166-0934(00)00144-0
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The reproducibility of population-based human immunodeficiency virus type 1 (HIV-I) protease and reverse transcriptase (RT) sequencing was assessed using replicate aliquots of cryopreserved plasma samples obtained from seven heavily treated HIV-1-infected individuals. The sequence of each sample replicate was compared with the consensus sequence for that sample and 99.4% of 35128 amino acids were found to be concordant with the sample consensus. Partial discordances were present at 0.5% of positions and complete discordances were present at <0.1% of positions. To assess the reproducibility at detecting mutations (defined here as differences from the subtype B consensus sequence), the proportion of sequences having a mutation when at least two sequences from that sample had the same mutation were examined. There was a median of 13 protease and 18 RT mutations per sample for a total of 3126 mutations; 95% of these mutations were detected. However, sequencing of multiple clones from two samples demonstrated that those mutations present in a minority of clones were often not detected by population-based sequencing. These results suggest that HIV-I protease and RT sequencing of circulating plasma virus is highly reproducible but that the sensitivity at detecting mutations may be low if those mutations are present as minor variants. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:143 / 153
页数:11
相关论文
共 50 条
  • [1] High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patients
    Shafer, RW
    Hertogs, K
    Zolopa, AR
    Warford, A
    Bloor, S
    Betts, BJ
    Merigan, TC
    Harrigan, R
    Larder, BA
    JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (04) : 1522 - 1529
  • [2] Polymorphism of the human immunodeficiency virus type 1 (HIV-1) protease gene and response of HIV-1-infected patients to a protease inhibitor
    Bossi, P
    Mouroux, M
    Yvon, A
    Bricaire, F
    Agut, H
    Huraux, JM
    Katlama, C
    Calvez, V
    JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (09) : 2910 - 2912
  • [3] Analysis of HIV-1 reverse transcriptase and protease sequences in paired plasma and lymphoid tissue specimens from HIV-1 infected individuals
    Erice, A
    Li, WY
    Balfour, HH
    Boies, LR
    Melroe, H
    Henry, K
    AIDS, 2001, 15 (07) : 831 - 836
  • [4] Evolutionarily Conserved Epitopes on Human Immunodeficiency Virus Type 1 (HIV-1) and Feline Immunodeficiency Virus Reverse Transcriptases Detected by HIV-1-Infected Subjects
    Sanou, Missa P.
    Roff, Shannon R.
    Mennella, Antony
    Sleasman, John W.
    Rathore, Mobeen H.
    Yamamoto, Janet K.
    Levy, Jay A.
    JOURNAL OF VIROLOGY, 2013, 87 (18) : 10004 - 10015
  • [5] Effect of human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein on HIV-1 reverse transcriptase activity in vitro
    Ji, XD
    Klarmann, GJ
    Preston, BD
    BIOCHEMISTRY, 1996, 35 (01) : 132 - 143
  • [6] Trends in human immunodeficiency virus type 1 (HIV-1) load among HIV-1-infected children with hemophilia
    Engels, EA
    Rosenberg, PS
    Katki, H
    Goedert, JJ
    Biggar, RJ
    JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (03): : 364 - 368
  • [7] Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients
    Moja, P
    Tranchat, C
    Tchou, I
    Pozzetto, B
    Lucht, F
    Desgranges, C
    Genin, C
    JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (05): : 1607 - 1613
  • [8] Human immunodeficiency virus type 1 (HIV-1) antigen secretion by latently infected resting CD4+ T lymphocytes from HIV-1-infected individuals
    Fondere, JM
    Petitjean, G
    Huguet, MF
    Salhi, SL
    Baillat, V
    Macura-Biegum, A
    Becquart, P
    Reynes, J
    Vendrell, JP
    JOURNAL OF VIROLOGY, 2004, 78 (19) : 10536 - 10542
  • [9] EPITOPES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) ENVELOPE GLYCOPROTEINS RECOGNIZED BY ANTIBODIES IN THE SERA OF HIV-1-INFECTED INDIVIDUALS
    KROWKA, JF
    SINGH, B
    STITES, DP
    MAINO, VC
    NARINDRAY, D
    HOLLANDER, H
    JAIN, S
    CHEN, H
    BLACKWOOD, L
    STEIMER, KS
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1991, 59 (01): : 53 - 64
  • [10] Activities of the human immunodeficiency virus type 1 (HIV-1) protease inhibitor nelfinavir mesylate in combination with reverse transcriptase and protease inhibitors against acute HIV-1 infection in vitro
    Patick, AK
    Boritzki, TJ
    Bloom, LA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (10) : 2159 - 2164